How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

It’s no secret that hospitals and health systems have been facing severe financial woes in the past couple years. These money problems have forced many providers to make what they likely felt were ...

The rise of digital health brought with it point solution fatigue as many employers and insurance carriers attempt to juggle multiple solutions at once. Recognizing this issue, Solera Health launched ...

Amid growing pressure on the U.S. healthcare system to meet the needs of its aging population, the Digital Medicine Society (DiMe) launched a new initiative this month to build a roadmap for ...

Amgen aims to challenge the Novo Nordisk and Eli Lilly duopoly in the market for injectable obesity medications, and the company is now preparing for Phase 3 testing of an injectable drug candidate ...

For newly diagnosed diabetes patients, understanding their condition and managing it can be scary and overwhelming and that can be especially true of children. To ease a bit of the headache, many ...

The use of Electronic Health Record (EHR) systems has revolutionized how healthcare is provided by allowing access to data and improving the coordination of care among medical professionals. But, the ...

One of the more competitive targets in lung cancer is a certain mutation that has eluded many available targeted therapies. A drug developed by Dizal Pharmaceutical has received FDA approval for ...

For a certain hormone deficiency inadequately managed with calcium and vitamin supplements, the only FDA-approved therapy is a daily injection that’s in limited supply and is set to exit the market ...

The Food and Drug Administration will remove black box warnings from hormone replacement therapy (HRT) products, which are often used to treat menopause, the Department of Health and Human Services ...

The Trump administration’s recent changes to the H-1B visa application process are causing concern among healthcare experts, with many worried that the plan could make the industry’s workforce crisis ...